��������

Steve Shimek is a seasoned professional in the life sciences sector, currently serving as Principal at Spotline Inc. since September 2022. Previously, Steve held multiple leadership roles at AbbVie and Allergan, including Program Director for R&D IT Acquisitions and Divestitures, where responsibility included managing intricate Mergers, Acquisitions, and Divestitures programs related to Research and Development Information Technology. Accomplishments involved establishing strategies for data transfer and integration, overseeing the harmonization of various IT systems, and directing major technology initiatives for knowledge management across multiple entities. Steve's career also includes significant contributions at Amgen, Cure Pharmaceutical, and Gilead Sciences, demonstrating a strong background in project management, information systems, and regulatory affairs. Educational credentials include an Executive Master's degree in Technology Management from Pepperdine Graziadio Business School and a Bachelor of Science degree in Computer Science from the University of Nebraska at Kearney.